CN103989808A - Compound granule - Google Patents
Compound granule Download PDFInfo
- Publication number
- CN103989808A CN103989808A CN201410270983.0A CN201410270983A CN103989808A CN 103989808 A CN103989808 A CN 103989808A CN 201410270983 A CN201410270983 A CN 201410270983A CN 103989808 A CN103989808 A CN 103989808A
- Authority
- CN
- China
- Prior art keywords
- extract
- asthenopia
- radix
- granular agent
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a compound granule, comprising the following raw materials: radix rehmanniae praeparata, pueraria, ginkgo leaf, salviae miltiorrhizae and the like, wherein one or more of a grape seed extract, a green tea extract and a bilberry extract also can be selectively added. Asthenopia can be effectively relieved by the compound granule.
Description
Technical field
The invention belongs to biomedicine field, be specifically related to a kind of compound granular agent.
Background technology
Asthenopia claims again eyestrain, in order to describe the noun of the series of symptoms relevant to excess eye-using.Because of it, to produce reason complexity various, most scholars think that asthenopic generation is the result that eye or whole body apparatus factors and psychologic factors are intertwined to form, belong to somatopsychic medicine's category, but conventionally taking the conscious eye symptom of patient as outstanding behaviours, therefore, be often called again clinically eyestrain's syndrome.Asthenopia symptom be usually expressed as eye pain, acid swollen, burn feeling, foreign body sensation, shed tears, photophobia, blurred vision, diplopia, eyes be dry and astringent, even causes eye inflammation and headache, reading can not.Especially when near work, far do not reach the eye condition of " comfortable and lasting ", the General Symptomies such as feeling sick even appears in severe patient, vomiting, severe jamming patient's vision and quality of life.Especially along with a large amount of of the video terminals such as computer popularize, make asthenopic incidence rate be the trend rising gradually.Therefore, asthenopic control more and more obtains people's concern.
The traditional Chinese medical science to asthenopia understanding early, is just attributed to " hepatic asthenia " category as far back as the Tang Dynasty.As Sun Simiao is pointed out in Thousand Golden Prescriptions: " its reading, game etc. excessively use order person says hepatic asthenia." and clearly propose to cause first 19 kinds of factors of ophthalmic, comprise " hypermetropia of looking as far as the eye can, number read life, night read thin book, read a book below the moon, copy for many years, chase spy, game endlessly, tears tear for many years " etc.The traditional Chinese medical science thinks, tiredly overtaxes one's nerves, consumes impairment of QI blood with working with one's mind, and causes the loss of Liver and kidney essence and blood, blood deficiency, and then causes eyeball distending pain, has a dizzy spell.Chinese traditional treatment asthenopia is followed nourishing the liver and kidney, replenishing blood for nourishing heart, harmonizing the functional activities of vital QI principle more, and conventional prescription comprises: ZHIBAIDIHUANG soup, GUIPI TANG and Danzhi Xiaoyao San etc.
The principle of work and power of health food alleviating asthenopia is mainly nursed one's health from three aspects:: element alleviating asthenopia 1. supplements the nutrients.The nutrients such as phylloxanthin, taurine, beta-carotene, vitamin can alleviating asthenopia.2. alleviate the asthenopia that ocular disease causes.The dialectical treatment of Chinese medicine entirety is seen is having unique curative effect aspect treatment asthenopia.3. alleviate the asthenopia that systemic disease causes.By the conditioning of the various diseases such as diabetes, anemia, hypertension, endocrine regulation is carried out to alleviating asthenopia.
Summary of the invention
The problem of comprehensive state of the art and existence, the present invention is based on the dialectical treatment theory of Chinese medicine entirety, and a kind of compound granular agent is provided, and it has unique curative effect aspect alleviating asthenopia.
For achieving the above object, the present invention is made up of following raw material: Radix Rehmanniae Preparata 5-8 part, Radix Puerariae 4-6 part, Folium Ginkgo 2-4 part, Radix Salviae Miltiorrhizae 2-5 part.
A kind of compound granular agent of the present invention, basic upper at mentioned component, can also selectivity adds one or more in Semen Vitis viniferae extract, green tea extract, Pericarpium Citri tangerinae extract.
Detailed description of the invention
Embodiment 1. the present invention are made up of following raw material: 7 parts of Radix Rehmanniae Preparata, 4 parts of Radix Puerariaes, 4 parts of Folium Ginkgos, 5 parts of Radix Salviae Miltiorrhizaes.
Embodiment 2. the present invention are made up of following raw material: 8 parts of Radix Rehmanniae Preparata, 6 parts of Radix Puerariaes, 2 parts of Folium Ginkgos, 2 parts of Radix Salviae Miltiorrhizaes.
Embodiment 3. the present invention are made up of following raw material: 5 parts of Radix Rehmanniae Preparata, 5 parts of Radix Puerariaes, 3 parts of Folium Ginkgos, 3 parts of Radix Salviae Miltiorrhizaes.
Embodiment 4. preparation method of the present invention: by after raw material pulverizing by 50 DEG C of reflux, extract, of 8 times of ethanol, filter, residue is used 80 DEG C of extractions of 10 times of water again, merge extracted twice liquid, concentrated, spraying is dry, adds the granulation agent such as appropriate Semen Vitis viniferae extract, green tea extract, Pericarpium Citri tangerinae extract, dextrin or starch.
Claims (3)
1. a compound granular agent, is made up of following raw material: Radix Rehmanniae Preparata 5-8 part, Radix Puerariae 4-6 part, Folium Ginkgo 2-4 part, Radix Salviae Miltiorrhizae 2-5 part.
2. a kind of compound granular agent according to claim 1, is characterized in that, can also selectivity adds one or more in Semen Vitis viniferae extract, green tea extract, Pericarpium Citri tangerinae extract.
3. according to a kind of compound granular agent described in claim 1-2, it is characterized in that, effectively alleviating asthenopia.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410270983.0A CN103989808A (en) | 2014-06-17 | 2014-06-17 | Compound granule |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410270983.0A CN103989808A (en) | 2014-06-17 | 2014-06-17 | Compound granule |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103989808A true CN103989808A (en) | 2014-08-20 |
Family
ID=51304308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410270983.0A Pending CN103989808A (en) | 2014-06-17 | 2014-06-17 | Compound granule |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103989808A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104524251A (en) * | 2014-12-03 | 2015-04-22 | 安徽哈博药业有限公司 | Folium ginkgo contained soft capsule for adjusting blood lipids |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001091770A2 (en) * | 2000-06-01 | 2001-12-06 | Theralife, Inc. | Compositions for treating eye discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins |
CN101524421A (en) * | 2008-12-31 | 2009-09-09 | 江西本草天工科技有限责任公司 | Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases |
-
2014
- 2014-06-17 CN CN201410270983.0A patent/CN103989808A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001091770A2 (en) * | 2000-06-01 | 2001-12-06 | Theralife, Inc. | Compositions for treating eye discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins |
CN101524421A (en) * | 2008-12-31 | 2009-09-09 | 江西本草天工科技有限责任公司 | Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases |
Non-Patent Citations (2)
Title |
---|
李佳等: "原花青素与熟地对小鼠免疫功能的影响", 《中国民族民间医药》, 15 June 2010 (2010-06-15) * |
秋彤: "《http://www.jkchina.org/newshtml/news_21927.htm》", 23 July 2013, article "保健食品详解:缓解视疲劳功能" * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104524251A (en) * | 2014-12-03 | 2015-04-22 | 安徽哈博药业有限公司 | Folium ginkgo contained soft capsule for adjusting blood lipids |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103285252A (en) | Oral liquid for alleviating hangover and protecting liver, and preparation method thereof | |
CN103417733B (en) | A kind of pharmaceutical composition of alleviating asthenopia | |
CN104256617B (en) | A kind of have the food of improving eyesight effect, health product or pharmaceutical composition | |
CN102550770B (en) | Mountain daisy coffee drink | |
CN103549068A (en) | Qi-tonifying and blood-nourishing bagged tea | |
CN104000201A (en) | Heath-care food capable of relieving visual fatigue | |
CN103989935B (en) | A kind of tranquilizing by nourishing the heart medicated wine and preparation method thereof | |
CN106106925A (en) | A kind of Radix Ginseng agate click alternative tea formula and production technology thereof | |
CN101862411B (en) | Chinese medicinal composition for treating acne | |
CN104397694A (en) | Eleutherococcus senticosus-fructus schizandrae oral liquid for improving sleep and production method thereof | |
CN1311856C (en) | Health-caring syrup | |
CN104115962A (en) | Tea capable of delaying menopause | |
CN106262850A (en) | A kind of miscellaneous grain crops health instant powder and production technology | |
CN102961611A (en) | Health-care medicinal liquor and preparation method thereof | |
CN103989808A (en) | Compound granule | |
CN103989822A (en) | Chrysanthemum-containing health product | |
CN105770506A (en) | Traditional Chinese medicine eye drops for alleviating asthenopia and preparation method thereof | |
CN103989821A (en) | Traditional Chinese medicine composition for improving asthenopia | |
CN104012973A (en) | Health-care food for reliving visual fatigue | |
CN105795006A (en) | Health-care edible oil with effects of restoring consciousness and improving eyesight and preparation method thereof | |
CN103989809A (en) | Health-care product and preparation method thereof | |
CN104012974A (en) | Health-care food containing chrysanthemum and preparation method thereof | |
CN109123674A (en) | A kind of black fruit fructus lycii compound alleviation visual fatigue piece and its preparation process | |
CN102961608A (en) | Traditional Chinese medicine for treating liver-yang hyperactivity type vertigo | |
CN105028837A (en) | Weight-reducing tea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140820 |